1h Free Analyst Time
The global cancer immunotherapy market is forecasted to grow by USD 53.89 billion during 2025-2030, accelerating at a CAGR of 8.3% during the forecast period. The report on the global cancer immunotherapy market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by expanding regulatory approvals for combination therapies, academic and technological advances in immune activation, advances in precision biomarker-driven immunotherapies.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.
The global cancer immunotherapy market is segmented as below:
By Type
- Monoclonal antibodies
- Check point inhibitors
- Cancer vaccines
By Application
- Lung cancer
- Breast cancer
- Colorectal cancer
- Others
By End-User
- Hospitals and clinics
- Cancer research centers
Geography
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Asia
- Rest of World (ROW)
- Rest of World (ROW)
The report on the global cancer immunotherapy market covers the following areas:
- Global cancer immunotherapy market sizing
- Global cancer immunotherapy market forecast
- Global cancer immunotherapy market industry analysis
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market by Geography
- Executive Summary - Chart on Market Segmentation by Type
- Executive Summary - Chart on Market Segmentation by Application
- Executive Summary - Chart on Market Segmentation by End-user
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning
2 Market Analysis
2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Chart on Overview on criticality of inputs and factors of differentiation
- Chart on Overview on factors of disruption
- Chart on Impact of drivers and challenges in 2025 and 2030
3 Market Landscape
3.1 Market ecosystem
- Chart on Parent Market
- Data Table on - Parent Market
- Chart on Market characteristics analysis
- Chart on Value chain analysis
4 Market Sizing
4.1 Market definition
4.4 Market outlook: Forecast for 2025-2030
- Data Table on Offerings of companies included in the market definition
- Market segments
4.4 Market outlook: Forecast for 2025-2030
- Chart on Global - Market size and forecast 2025-2030 ($ million)
- Data Table on Global - Market size and forecast 2025-2030 ($ million)
- Chart on Global Market: Year-over-year growth 2025-2030 (%)
- Data Table on Global Market: Year-over-year growth 2025-2030 (%)
5 Historic Market Size
5.1 Global Cancer Immunotherapy Market 2020 - 2024
- Historic Market Size - Data Table on Global Cancer Immunotherapy Market 2020 - 2024 ($ million)
- Historic Market Size - Type Segment 2020 - 2024 ($ million)
- Historic Market Size - Application Segment 2020 - 2024 ($ million)
- Historic Market Size - End-user Segment 2020 - 2024 ($ million)
- Historic Market Size - Geography Segment 2020 - 2024 ($ million)
- Historic Market Size - Country Segment 2020 - 2024 ($ million)
6 Qualitative Analysis
6.1 Impact of AI on Global Cancer Immunotherapy Market
6.2 Impact of Geopolitical Conflicts on Global Cancer Immunotherapy Market
6.2 Impact of Geopolitical Conflicts on Global Cancer Immunotherapy Market
7 Five Forces Analysis
7.1 Five forces summary
- Five forces analysis - Comparison between 2025 and 2030
- Bargaining power of buyers - Impact of key factors 2025 and 2030
- Bargaining power of suppliers - Impact of key factors in 2025 and 2030
- Threat of new entrants - Impact of key factors in 2025 and 2030
- Threat of substitutes - Impact of key factors in 2025 and 2030
- Threat of rivalry - Impact of key factors in 2025 and 2030
- Chart on Market condition - Five forces 2025 and 2030
8 Market Segmentation by Type
8.1 Market segments
- Chart on Type - Market share 2025-2030 (%)
- Data Table on Type - Market share 2025-2030 (%)
- Chart on Comparison by Type
- Data Table on Comparison by Type
- Chart on Monoclonal antibodies - Market size and forecast 2025-2030 ($ million)
- Data Table on Monoclonal antibodies - Market size and forecast 2025-2030 ($ million)
- Chart on Monoclonal antibodies - Year-over-year growth 2025-2030 (%)
- Data Table on Monoclonal antibodies - Year-over-year growth 2025-2030 (%)
- Chart on Check point inhibitors - Market size and forecast 2025-2030 ($ million)
- Data Table on Check point inhibitors - Market size and forecast 2025-2030 ($ million)
- Chart on Check point inhibitors - Year-over-year growth 2025-2030 (%)
- Data Table on Check point inhibitors - Year-over-year growth 2025-2030 (%)
- Chart on Cancer vaccines - Market size and forecast 2025-2030 ($ million)
- Data Table on Cancer vaccines - Market size and forecast 2025-2030 ($ million)
- Chart on Cancer vaccines - Year-over-year growth 2025-2030 (%)
- Data Table on Cancer vaccines - Year-over-year growth 2025-2030 (%)
- Market opportunity by Type ($ million)
- Data Table on Market opportunity by Type ($ million)
9 Market Segmentation by Application
9.1 Market segments
- Chart on Application - Market share 2025-2030 (%)
- Data Table on Application - Market share 2025-2030 (%)
- Chart on Comparison by Application
- Data Table on Comparison by Application
- Chart on Lung cancer - Market size and forecast 2025-2030 ($ million)
- Data Table on Lung cancer - Market size and forecast 2025-2030 ($ million)
- Chart on Lung cancer - Year-over-year growth 2025-2030 (%)
- Data Table on Lung cancer - Year-over-year growth 2025-2030 (%)
- Chart on Breast cancer - Market size and forecast 2025-2030 ($ million)
- Data Table on Breast cancer - Market size and forecast 2025-2030 ($ million)
- Chart on Breast cancer - Year-over-year growth 2025-2030 (%)
- Data Table on Breast cancer - Year-over-year growth 2025-2030 (%)
- Chart on Colorectal cancer - Market size and forecast 2025-2030 ($ million)
- Data Table on Colorectal cancer - Market size and forecast 2025-2030 ($ million)
- Chart on Colorectal cancer - Year-over-year growth 2025-2030 (%)
- Data Table on Colorectal cancer - Year-over-year growth 2025-2030 (%)
- Chart on Others - Market size and forecast 2025-2030 ($ million)
- Data Table on Others - Market size and forecast 2025-2030 ($ million)
- Chart on Others - Year-over-year growth 2025-2030 (%)
- Data Table on Others - Year-over-year growth 2025-2030 (%)
- Market opportunity by Application ($ million)
- Data Table on Market opportunity by Application ($ million)
10 Market Segmentation by End-user
10.1 Market segments
- Chart on End-user - Market share 2025-2030 (%)
- Data Table on End-user - Market share 2025-2030 (%)
- Chart on Comparison by End-user
- Data Table on Comparison by End-user
- Chart on Hospitals and clinics - Market size and forecast 2025-2030 ($ million)
- Data Table on Hospitals and clinics - Market size and forecast 2025-2030 ($ million)
- Chart on Hospitals and clinics - Year-over-year growth 2025-2030 (%)
- Data Table on Hospitals and clinics - Year-over-year growth 2025-2030 (%)
- Chart on Cancer research centers - Market size and forecast 2025-2030 ($ million)
- Data Table on Cancer research centers - Market size and forecast 2025-2030 ($ million)
- Chart on Cancer research centers - Year-over-year growth 2025-2030 (%)
- Data Table on Cancer research centers - Year-over-year growth 2025-2030 (%)
- Market opportunity by End-user ($ million)
- Data Table on Market opportunity by End-user ($ million)
11 Customer Landscape
11.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
12 Geographic Landscape
12.1 Geographic segmentation
- Chart on Market share by geography 2025-2030 (%)
- Data Table on Market share by geography 2025-2030 (%)
- Chart on Geographic comparison
- Data Table on Geographic comparison
- Chart on North America - Market size and forecast 2025-2030 ($ million)
- Data Table on North America - Market size and forecast 2025-2030 ($ million)
- Chart on North America - Year-over-year growth 2025-2030 (%)
- Data Table on North America - Year-over-year growth 2025-2030 (%)
- Chart on Regional Comparison - North America
- Data Table on Regional Comparison - North America
- Chart on US - Market size and forecast 2025-2030 ($ million)
- Data Table on US - Market size and forecast 2025-2030 ($ million)
- Chart on US - Year-over-year growth 2025-2030 (%)
- Data Table on US - Year-over-year growth 2025-2030 (%)
- Chart on Canada - Market size and forecast 2025-2030 ($ million)
- Data Table on Canada - Market size and forecast 2025-2030 ($ million)
- Chart on Canada - Year-over-year growth 2025-2030 (%)
- Data Table on Canada - Year-over-year growth 2025-2030 (%)
- Chart on Mexico - Market size and forecast 2025-2030 ($ million)
- Data Table on Mexico - Market size and forecast 2025-2030 ($ million)
- Chart on Mexico - Year-over-year growth 2025-2030 (%)
- Data Table on Mexico - Year-over-year growth 2025-2030 (%)
- Chart on Europe - Market size and forecast 2025-2030 ($ million)
- Data Table on Europe - Market size and forecast 2025-2030 ($ million)
- Chart on Europe - Year-over-year growth 2025-2030 (%)
- Data Table on Europe - Year-over-year growth 2025-2030 (%)
- Chart on Regional Comparison - Europe
- Data Table on Regional Comparison - Europe
- Chart on Germany - Market size and forecast 2025-2030 ($ million)
- Data Table on Germany - Market size and forecast 2025-2030 ($ million)
- Chart on Germany - Year-over-year growth 2025-2030 (%)
- Data Table on Germany - Year-over-year growth 2025-2030 (%)
- Chart on UK - Market size and forecast 2025-2030 ($ million)
- Data Table on UK - Market size and forecast 2025-2030 ($ million)
- Chart on UK - Year-over-year growth 2025-2030 (%)
- Data Table on UK - Year-over-year growth 2025-2030 (%)
- Chart on France - Market size and forecast 2025-2030 ($ million)
- Data Table on France - Market size and forecast 2025-2030 ($ million)
- Chart on France - Year-over-year growth 2025-2030 (%)
- Data Table on France - Year-over-year growth 2025-2030 (%)
- Chart on Italy - Market size and forecast 2025-2030 ($ million)
- Data Table on Italy - Market size and forecast 2025-2030 ($ million)
- Chart on Italy - Year-over-year growth 2025-2030 (%)
- Data Table on Italy - Year-over-year growth 2025-2030 (%)
- Chart on Spain - Market size and forecast 2025-2030 ($ million)
- Data Table on Spain - Market size and forecast 2025-2030 ($ million)
- Chart on Spain - Year-over-year growth 2025-2030 (%)
- Data Table on Spain - Year-over-year growth 2025-2030 (%)
- Chart on The Netherlands - Market size and forecast 2025-2030 ($ million)
- Data Table on The Netherlands - Market size and forecast 2025-2030 ($ million)
- Chart on The Netherlands - Year-over-year growth 2025-2030 (%)
- Data Table on The Netherlands - Year-over-year growth 2025-2030 (%)
- Chart on Asia - Market size and forecast 2025-2030 ($ million)
- Data Table on Asia - Market size and forecast 2025-2030 ($ million)
- Chart on Asia - Year-over-year growth 2025-2030 (%)
- Data Table on Asia - Year-over-year growth 2025-2030 (%)
- Chart on Regional Comparison - Asia
- Data Table on Regional Comparison - Asia
- Chart on Japan - Market size and forecast 2025-2030 ($ million)
- Data Table on Japan - Market size and forecast 2025-2030 ($ million)
- Chart on Japan - Year-over-year growth 2025-2030 (%)
- Data Table on Japan - Year-over-year growth 2025-2030 (%)
- Chart on China - Market size and forecast 2025-2030 ($ million)
- Data Table on China - Market size and forecast 2025-2030 ($ million)
- Chart on China - Year-over-year growth 2025-2030 (%)
- Data Table on China - Year-over-year growth 2025-2030 (%)
- Chart on India - Market size and forecast 2025-2030 ($ million)
- Data Table on India - Market size and forecast 2025-2030 ($ million)
- Chart on India - Year-over-year growth 2025-2030 (%)
- Data Table on India - Year-over-year growth 2025-2030 (%)
- Chart on South Korea - Market size and forecast 2025-2030 ($ million)
- Data Table on South Korea - Market size and forecast 2025-2030 ($ million)
- Chart on South Korea - Year-over-year growth 2025-2030 (%)
- Data Table on South Korea - Year-over-year growth 2025-2030 (%)
- Chart on Taiwan - Market size and forecast 2025-2030 ($ million)
- Data Table on Taiwan - Market size and forecast 2025-2030 ($ million)
- Chart on Taiwan - Year-over-year growth 2025-2030 (%)
- Data Table on Taiwan - Year-over-year growth 2025-2030 (%)
- Chart on Singapore - Market size and forecast 2025-2030 ($ million)
- Data Table on Singapore - Market size and forecast 2025-2030 ($ million)
- Chart on Singapore - Year-over-year growth 2025-2030 (%)
- Data Table on Singapore - Year-over-year growth 2025-2030 (%)
- Chart on Rest of World (ROW) - Market size and forecast 2025-2030 ($ million)
- Data Table on Rest of World (ROW) - Market size and forecast 2025-2030 ($ million)
- Chart on Rest of World (ROW) - Year-over-year growth 2025-2030 (%)
- Data Table on Rest of World (ROW) - Year-over-year growth 2025-2030 (%)
- Chart on Regional Comparison - Rest of World (ROW)
- Data Table on Regional Comparison - Rest of World (ROW)
- Chart on Brazil - Market size and forecast 2025-2030 ($ million)
- Data Table on Brazil - Market size and forecast 2025-2030 ($ million)
- Chart on Brazil - Year-over-year growth 2025-2030 (%)
- Data Table on Brazil - Year-over-year growth 2025-2030 (%)
- Chart on Saudi Arabia - Market size and forecast 2025-2030 ($ million)
- Data Table on Saudi Arabia - Market size and forecast 2025-2030 ($ million)
- Chart on Saudi Arabia - Year-over-year growth 2025-2030 (%)
- Data Table on Saudi Arabia - Year-over-year growth 2025-2030 (%)
- Chart on South Africa - Market size and forecast 2025-2030 ($ million)
- Data Table on South Africa - Market size and forecast 2025-2030 ($ million)
- Chart on South Africa - Year-over-year growth 2025-2030 (%)
- Data Table on South Africa - Year-over-year growth 2025-2030 (%)
- Chart on Turkey - Market size and forecast 2025-2030 ($ million)
- Data Table on Turkey - Market size and forecast 2025-2030 ($ million)
- Chart on Turkey - Year-over-year growth 2025-2030 (%)
- Data Table on Turkey - Year-over-year growth 2025-2030 (%)
- Chart on UAE - Market size and forecast 2025-2030 ($ million)
- Data Table on UAE - Market size and forecast 2025-2030 ($ million)
- Chart on UAE - Year-over-year growth 2025-2030 (%)
- Data Table on UAE - Year-over-year growth 2025-2030 (%)
- Chart on Argentina - Market size and forecast 2025-2030 ($ million)
- Data Table on Argentina - Market size and forecast 2025-2030 ($ million)
- Chart on Argentina - Year-over-year growth 2025-2030 (%)
- Data Table on Argentina - Year-over-year growth 2025-2030 (%)
- Chart on Israel - Market size and forecast 2025-2030 ($ million)
- Data Table on Israel - Market size and forecast 2025-2030 ($ million)
- Chart on Israel - Year-over-year growth 2025-2030 (%)
- Data Table on Israel - Year-over-year growth 2025-2030 (%)
- Chart on Colombia - Market size and forecast 2025-2030 ($ million)
- Data Table on Colombia - Market size and forecast 2025-2030 ($ million)
- Chart on Colombia - Year-over-year growth 2025-2030 (%)
- Data Table on Colombia - Year-over-year growth 2025-2030 (%)
- Market opportunity by geography ($ million)
- Data Tables on Market opportunity by geography ($ million)
13 Drivers, Challenges, and Opportunity
13.1 Market drivers
- Expanding regulatory approvals for combination therapies
- Academic and technological advances in immune activation
- Advances in precision biomarker-driven immunotherapies
- Manufacturing complexities and supply chain vulnerabilities
- Stringent regulatory hurdles and clinical trial inefficiencies
- Severe immune related adverse events and safety profile management
- Impact of drivers and challenges in 2025 and 2030
- Advances in CAR cell therapies for complex cancers
- Strategic collaborations and manufacturing agreements
- Advances in personalized mRNA cancer vaccines
14 Competitive Landscape
14.1 Overview
14.2 Competitive Landscape
14.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
- Overview on factors of disruption
- Impact of key risks on business
15 Competitive Analysis
15.1 Companies profiled
- Companies covered
- Company ranking index
- Matrix on companies position and classification
- AbbVie Inc. - Overview
- AbbVie Inc. - Business segments
- AbbVie Inc. - Key news
- AbbVie Inc. - Key offerings
- AbbVie Inc. - Segment focus
- SWOT
- Amgen Inc. - Overview
- Amgen Inc. - Product / Service
- Amgen Inc. - Key news
- Amgen Inc. - Key offerings
- SWOT
- AstraZeneca Plc - Overview
- AstraZeneca Plc - Business segments
- AstraZeneca Plc - Key news
- AstraZeneca Plc - Key offerings
- AstraZeneca Plc - Segment focus
- SWOT
- Bayer AG - Overview
- Bayer AG - Business segments
- Bayer AG - Key news
- Bayer AG - Key offerings
- Bayer AG - Segment focus
- SWOT
- BioNTech SE - Overview
- BioNTech SE - Product / Service
- BioNTech SE - Key offerings
- SWOT
- Bristol Myers Squibb Co. - Overview
- Bristol Myers Squibb Co. - Product / Service
- Bristol Myers Squibb Co. - Key news
- Bristol Myers Squibb Co. - Key offerings
- SWOT
- Eli Lilly and Co. - Overview
- Eli Lilly and Co. - Product / Service
- Eli Lilly and Co. - Key news
- Eli Lilly and Co. - Key offerings
- SWOT
- F. Hoffmann La Roche Ltd. - Overview
- F. Hoffmann La Roche Ltd. - Business segments
- F. Hoffmann La Roche Ltd. - Key news
- F. Hoffmann La Roche Ltd. - Key offerings
- F. Hoffmann La Roche Ltd. - Segment focus
- SWOT
- GlaxoSmithKline Plc - Overview
- GlaxoSmithKline Plc - Business segments
- GlaxoSmithKline Plc - Key news
- GlaxoSmithKline Plc - Key offerings
- GlaxoSmithKline Plc - Segment focus
- SWOT
- Ipsen Pharma - Overview
- Ipsen Pharma - Business segments
- Ipsen Pharma - Key offerings
- Ipsen Pharma - Segment focus
- SWOT
- Merck and Co. Inc. - Overview
- Merck and Co. Inc. - Business segments
- Merck and Co. Inc. - Key news
- Merck and Co. Inc. - Key offerings
- Merck and Co. Inc. - Segment focus
- SWOT
- Novartis AG - Overview
- Novartis AG - Business segments
- Novartis AG - Key news
- Novartis AG - Key offerings
- Novartis AG - Segment focus
- SWOT
- Sanofi SA - Overview
- Sanofi SA - Business segments
- Sanofi SA - Key news
- Sanofi SA - Key offerings
- Sanofi SA - Segment focus
- SWOT
- Takeda Pharmaceutical Ltd. - Overview
- Takeda Pharmaceutical Ltd. - Business segments
- Takeda Pharmaceutical Ltd. - Key news
- Takeda Pharmaceutical Ltd. - Key offerings
- Takeda Pharmaceutical Ltd. - Segment focus
- SWOT
- Thermo Fisher Scientific Inc. - Overview
- Thermo Fisher Scientific Inc. - Business segments
- Thermo Fisher Scientific Inc. - Key news
- Thermo Fisher Scientific Inc. - Key offerings
- Thermo Fisher Scientific Inc. - Segment focus
- SWOT
16 Appendix
16.1 Scope of the report
- Market definition
- Objectives
- Notes and caveats
- Inclusions checklist
- Exclusions checklist
- Currency conversion rates for US$
- Research methodology
- Information sources
- Data validation
- Validation techniques employed for market sizing
- Data synthesis
- 360 degree market analysis
- List of abbreviations
List of Exhibits
Exhibit 1: Executive Summary - Chart on Market Overview
Exhibit 2: Executive Summary - Data Table on Market Overview
Exhibit 3: Executive Summary - Chart on Global Market Characteristics
Exhibit 4: Executive Summary - Chart on Market by Geography
Exhibit 5: Executive Summary - Chart on Market Segmentation by Type
Exhibit 6: Executive Summary - Chart on Market Segmentation by Application
Exhibit 7: Executive Summary - Chart on Market Segmentation by End-user
Exhibit 8: Executive Summary - Chart on Incremental Growth
Exhibit 9: Executive Summary - Data Table on Incremental Growth
Exhibit 10: Executive Summary - Chart on Company Market Positioning
Exhibit 11: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibit 12: Chart on Overview on criticality of inputs and factors of differentiation
Exhibit 13: Chart on Overview on factors of disruption
Exhibit 14: Chart on Impact of drivers and challenges in 2025 and 2030
Exhibit 15: Chart on Parent Market
Exhibit 16: Data Table on - Parent Market
Exhibit 17: Chart on Market characteristics analysis
Exhibit 18: Chart on Value chain analysis
Exhibit 19: Data Table on Offerings of companies included in the market definition
Exhibit 20: Market segments
Exhibit 21: Chart on Global - Market size and forecast 2025-2030 ($ million)
Exhibit 22: Data Table on Global - Market size and forecast 2025-2030 ($ million)
Exhibit 23: Chart on Global Market: Year-over-year growth 2025-2030 (%)
Exhibit 24: Data Table on Global Market: Year-over-year growth 2025-2030 (%)
Exhibit 25: Historic Market Size - Data Table on Global Cancer Immunotherapy Market 2020 - 2024 ($ million)
Exhibit 26: Historic Market Size - Type Segment 2020 - 2024 ($ million)
Exhibit 27: Historic Market Size - Application Segment 2020 - 2024 ($ million)
Exhibit 28: Historic Market Size - End-user Segment 2020 - 2024 ($ million)
Exhibit 29: Historic Market Size - Geography Segment 2020 - 2024 ($ million)
Exhibit 30: Historic Market Size - Country Segment 2020 - 2024 ($ million)
Exhibit 31: Five forces analysis - Comparison between 2025 and 2030
Exhibit 32: Bargaining power of buyers - Impact of key factors 2025 and 2030
Exhibit 33: Bargaining power of suppliers - Impact of key factors in 2025 and 2030
Exhibit 34: Threat of new entrants - Impact of key factors in 2025 and 2030
Exhibit 35: Threat of substitutes - Impact of key factors in 2025 and 2030
Exhibit 36: Threat of rivalry - Impact of key factors in 2025 and 2030
Exhibit 37: Chart on Market condition - Five forces 2025 and 2030
Exhibit 38: Chart on Type - Market share 2025-2030 (%)
Exhibit 39: Data Table on Type - Market share 2025-2030 (%)
Exhibit 40: Chart on Comparison by Type
Exhibit 41: Data Table on Comparison by Type
Exhibit 42: Chart on Monoclonal antibodies - Market size and forecast 2025-2030 ($ million)
Exhibit 43: Data Table on Monoclonal antibodies - Market size and forecast 2025-2030 ($ million)
Exhibit 44: Chart on Monoclonal antibodies - Year-over-year growth 2025-2030 (%)
Exhibit 45: Data Table on Monoclonal antibodies - Year-over-year growth 2025-2030 (%)
Exhibit 46: Chart on Check point inhibitors - Market size and forecast 2025-2030 ($ million)
Exhibit 47: Data Table on Check point inhibitors - Market size and forecast 2025-2030 ($ million)
Exhibit 48: Chart on Check point inhibitors - Year-over-year growth 2025-2030 (%)
Exhibit 49: Data Table on Check point inhibitors - Year-over-year growth 2025-2030 (%)
Exhibit 50: Chart on Cancer vaccines - Market size and forecast 2025-2030 ($ million)
Exhibit 51: Data Table on Cancer vaccines - Market size and forecast 2025-2030 ($ million)
Exhibit 52: Chart on Cancer vaccines - Year-over-year growth 2025-2030 (%)
Exhibit 53: Data Table on Cancer vaccines - Year-over-year growth 2025-2030 (%)
Exhibit 54: Market opportunity by Type ($ million)
Exhibit 55: Data Table on Market opportunity by Type ($ million)
Exhibit 56: Chart on Application - Market share 2025-2030 (%)
Exhibit 57: Data Table on Application - Market share 2025-2030 (%)
Exhibit 58: Chart on Comparison by Application
Exhibit 59: Data Table on Comparison by Application
Exhibit 60: Chart on Lung cancer - Market size and forecast 2025-2030 ($ million)
Exhibit 61: Data Table on Lung cancer - Market size and forecast 2025-2030 ($ million)
Exhibit 62: Chart on Lung cancer - Year-over-year growth 2025-2030 (%)
Exhibit 63: Data Table on Lung cancer - Year-over-year growth 2025-2030 (%)
Exhibit 64: Chart on Breast cancer - Market size and forecast 2025-2030 ($ million)
Exhibit 65: Data Table on Breast cancer - Market size and forecast 2025-2030 ($ million)
Exhibit 66: Chart on Breast cancer - Year-over-year growth 2025-2030 (%)
Exhibit 67: Data Table on Breast cancer - Year-over-year growth 2025-2030 (%)
Exhibit 68: Chart on Colorectal cancer - Market size and forecast 2025-2030 ($ million)
Exhibit 69: Data Table on Colorectal cancer - Market size and forecast 2025-2030 ($ million)
Exhibit 70: Chart on Colorectal cancer - Year-over-year growth 2025-2030 (%)
Exhibit 71: Data Table on Colorectal cancer - Year-over-year growth 2025-2030 (%)
Exhibit 72: Chart on Others - Market size and forecast 2025-2030 ($ million)
Exhibit 73: Data Table on Others - Market size and forecast 2025-2030 ($ million)
Exhibit 74: Chart on Others - Year-over-year growth 2025-2030 (%)
Exhibit 75: Data Table on Others - Year-over-year growth 2025-2030 (%)
Exhibit 76: Market opportunity by Application ($ million)
Exhibit 77: Data Table on Market opportunity by Application ($ million)
Exhibit 78: Chart on End-user - Market share 2025-2030 (%)
Exhibit 79: Data Table on End-user - Market share 2025-2030 (%)
Exhibit 80: Chart on Comparison by End-user
Exhibit 81: Data Table on Comparison by End-user
Exhibit 82: Chart on Hospitals and clinics - Market size and forecast 2025-2030 ($ million)
Exhibit 83: Data Table on Hospitals and clinics - Market size and forecast 2025-2030 ($ million)
Exhibit 84: Chart on Hospitals and clinics - Year-over-year growth 2025-2030 (%)
Exhibit 85: Data Table on Hospitals and clinics - Year-over-year growth 2025-2030 (%)
Exhibit 86: Chart on Cancer research centers - Market size and forecast 2025-2030 ($ million)
Exhibit 87: Data Table on Cancer research centers - Market size and forecast 2025-2030 ($ million)
Exhibit 88: Chart on Cancer research centers - Year-over-year growth 2025-2030 (%)
Exhibit 89: Data Table on Cancer research centers - Year-over-year growth 2025-2030 (%)
Exhibit 90: Market opportunity by End-user ($ million)
Exhibit 91: Data Table on Market opportunity by End-user ($ million)
Exhibit 92: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibit 93: Chart on Market share by geography 2025-2030 (%)
Exhibit 94: Data Table on Market share by geography 2025-2030 (%)
Exhibit 95: Chart on Geographic comparison
Exhibit 96: Data Table on Geographic comparison
Exhibit 97: Chart on North America - Market size and forecast 2025-2030 ($ million)
Exhibit 98: Data Table on North America - Market size and forecast 2025-2030 ($ million)
Exhibit 99: Chart on North America - Year-over-year growth 2025-2030 (%)
Exhibit 100: Data Table on North America - Year-over-year growth 2025-2030 (%)
Exhibit 101: Chart on Regional Comparison - North America
Exhibit 102: Data Table on Regional Comparison - North America
Exhibit 103: Chart on US - Market size and forecast 2025-2030 ($ million)
Exhibit 104: Data Table on US - Market size and forecast 2025-2030 ($ million)
Exhibit 105: Chart on US - Year-over-year growth 2025-2030 (%)
Exhibit 106: Data Table on US - Year-over-year growth 2025-2030 (%)
Exhibit 107: Chart on Canada - Market size and forecast 2025-2030 ($ million)
Exhibit 108: Data Table on Canada - Market size and forecast 2025-2030 ($ million)
Exhibit 109: Chart on Canada - Year-over-year growth 2025-2030 (%)
Exhibit 110: Data Table on Canada - Year-over-year growth 2025-2030 (%)
Exhibit 111: Chart on Mexico - Market size and forecast 2025-2030 ($ million)
Exhibit 112: Data Table on Mexico - Market size and forecast 2025-2030 ($ million)
Exhibit 113: Chart on Mexico - Year-over-year growth 2025-2030 (%)
Exhibit 114: Data Table on Mexico - Year-over-year growth 2025-2030 (%)
Exhibit 115: Chart on Europe - Market size and forecast 2025-2030 ($ million)
Exhibit 116: Data Table on Europe - Market size and forecast 2025-2030 ($ million)
Exhibit 117: Chart on Europe - Year-over-year growth 2025-2030 (%)
Exhibit 118: Data Table on Europe - Year-over-year growth 2025-2030 (%)
Exhibit 119: Chart on Regional Comparison - Europe
Exhibit 120: Data Table on Regional Comparison - Europe
Exhibit 121: Chart on Germany - Market size and forecast 2025-2030 ($ million)
Exhibit 122: Data Table on Germany - Market size and forecast 2025-2030 ($ million)
Exhibit 123: Chart on Germany - Year-over-year growth 2025-2030 (%)
Exhibit 124: Data Table on Germany - Year-over-year growth 2025-2030 (%)
Exhibit 125: Chart on UK - Market size and forecast 2025-2030 ($ million)
Exhibit 126: Data Table on UK - Market size and forecast 2025-2030 ($ million)
Exhibit 127: Chart on UK - Year-over-year growth 2025-2030 (%)
Exhibit 128: Data Table on UK - Year-over-year growth 2025-2030 (%)
Exhibit 129: Chart on France - Market size and forecast 2025-2030 ($ million)
Exhibit 130: Data Table on France - Market size and forecast 2025-2030 ($ million)
Exhibit 131: Chart on France - Year-over-year growth 2025-2030 (%)
Exhibit 132: Data Table on France - Year-over-year growth 2025-2030 (%)
Exhibit 133: Chart on Italy - Market size and forecast 2025-2030 ($ million)
Exhibit 134: Data Table on Italy - Market size and forecast 2025-2030 ($ million)
Exhibit 135: Chart on Italy - Year-over-year growth 2025-2030 (%)
Exhibit 136: Data Table on Italy - Year-over-year growth 2025-2030 (%)
Exhibit 137: Chart on Spain - Market size and forecast 2025-2030 ($ million)
Exhibit 138: Data Table on Spain - Market size and forecast 2025-2030 ($ million)
Exhibit 139: Chart on Spain - Year-over-year growth 2025-2030 (%)
Exhibit 140: Data Table on Spain - Year-over-year growth 2025-2030 (%)
Exhibit 141: Chart on The Netherlands - Market size and forecast 2025-2030 ($ million)
Exhibit 142: Data Table on The Netherlands - Market size and forecast 2025-2030 ($ million)
Exhibit 143: Chart on The Netherlands - Year-over-year growth 2025-2030 (%)
Exhibit 144: Data Table on The Netherlands - Year-over-year growth 2025-2030 (%)
Exhibit 145: Chart on Asia - Market size and forecast 2025-2030 ($ million)
Exhibit 146: Data Table on Asia - Market size and forecast 2025-2030 ($ million)
Exhibit 147: Chart on Asia - Year-over-year growth 2025-2030 (%)
Exhibit 148: Data Table on Asia - Year-over-year growth 2025-2030 (%)
Exhibit 149: Chart on Regional Comparison - Asia
Exhibit 150: Data Table on Regional Comparison - Asia
Exhibit 151: Chart on Japan - Market size and forecast 2025-2030 ($ million)
Exhibit 152: Data Table on Japan - Market size and forecast 2025-2030 ($ million)
Exhibit 153: Chart on Japan - Year-over-year growth 2025-2030 (%)
Exhibit 154: Data Table on Japan - Year-over-year growth 2025-2030 (%)
Exhibit 155: Chart on China - Market size and forecast 2025-2030 ($ million)
Exhibit 156: Data Table on China - Market size and forecast 2025-2030 ($ million)
Exhibit 157: Chart on China - Year-over-year growth 2025-2030 (%)
Exhibit 158: Data Table on China - Year-over-year growth 2025-2030 (%)
Exhibit 159: Chart on India - Market size and forecast 2025-2030 ($ million)
Exhibit 160: Data Table on India - Market size and forecast 2025-2030 ($ million)
Exhibit 161: Chart on India - Year-over-year growth 2025-2030 (%)
Exhibit 162: Data Table on India - Year-over-year growth 2025-2030 (%)
Exhibit 163: Chart on South Korea - Market size and forecast 2025-2030 ($ million)
Exhibit 164: Data Table on South Korea - Market size and forecast 2025-2030 ($ million)
Exhibit 165: Chart on South Korea - Year-over-year growth 2025-2030 (%)
Exhibit 166: Data Table on South Korea - Year-over-year growth 2025-2030 (%)
Exhibit 167: Chart on Taiwan - Market size and forecast 2025-2030 ($ million)
Exhibit 168: Data Table on Taiwan - Market size and forecast 2025-2030 ($ million)
Exhibit 169: Chart on Taiwan - Year-over-year growth 2025-2030 (%)
Exhibit 170: Data Table on Taiwan - Year-over-year growth 2025-2030 (%)
Exhibit 171: Chart on Singapore - Market size and forecast 2025-2030 ($ million)
Exhibit 172: Data Table on Singapore - Market size and forecast 2025-2030 ($ million)
Exhibit 173: Chart on Singapore - Year-over-year growth 2025-2030 (%)
Exhibit 174: Data Table on Singapore - Year-over-year growth 2025-2030 (%)
Exhibit 175: Chart on Rest of World (ROW) - Market size and forecast 2025-2030 ($ million)
Exhibit 176: Data Table on Rest of World (ROW) - Market size and forecast 2025-2030 ($ million)
Exhibit 177: Chart on Rest of World (ROW) - Year-over-year growth 2025-2030 (%)
Exhibit 178: Data Table on Rest of World (ROW) - Year-over-year growth 2025-2030 (%)
Exhibit 179: Chart on Regional Comparison - Rest of World (ROW)
Exhibit 180: Data Table on Regional Comparison - Rest of World (ROW)
Exhibit 181: Chart on Brazil - Market size and forecast 2025-2030 ($ million)
Exhibit 182: Data Table on Brazil - Market size and forecast 2025-2030 ($ million)
Exhibit 183: Chart on Brazil - Year-over-year growth 2025-2030 (%)
Exhibit 184: Data Table on Brazil - Year-over-year growth 2025-2030 (%)
Exhibit 185: Chart on Saudi Arabia - Market size and forecast 2025-2030 ($ million)
Exhibit 186: Data Table on Saudi Arabia - Market size and forecast 2025-2030 ($ million)
Exhibit 187: Chart on Saudi Arabia - Year-over-year growth 2025-2030 (%)
Exhibit 188: Data Table on Saudi Arabia - Year-over-year growth 2025-2030 (%)
Exhibit 189: Chart on South Africa - Market size and forecast 2025-2030 ($ million)
Exhibit 190: Data Table on South Africa - Market size and forecast 2025-2030 ($ million)
Exhibit 191: Chart on South Africa - Year-over-year growth 2025-2030 (%)
Exhibit 192: Data Table on South Africa - Year-over-year growth 2025-2030 (%)
Exhibit 193: Chart on Turkey - Market size and forecast 2025-2030 ($ million)
Exhibit 194: Data Table on Turkey - Market size and forecast 2025-2030 ($ million)
Exhibit 195: Chart on Turkey - Year-over-year growth 2025-2030 (%)
Exhibit 196: Data Table on Turkey - Year-over-year growth 2025-2030 (%)
Exhibit 197: Chart on UAE - Market size and forecast 2025-2030 ($ million)
Exhibit 198: Data Table on UAE - Market size and forecast 2025-2030 ($ million)
Exhibit 199: Chart on UAE - Year-over-year growth 2025-2030 (%)
Exhibit 200: Data Table on UAE - Year-over-year growth 2025-2030 (%)
Exhibit 201: Chart on Argentina - Market size and forecast 2025-2030 ($ million)
Exhibit 202: Data Table on Argentina - Market size and forecast 2025-2030 ($ million)
Exhibit 203: Chart on Argentina - Year-over-year growth 2025-2030 (%)
Exhibit 204: Data Table on Argentina - Year-over-year growth 2025-2030 (%)
Exhibit 205: Chart on Israel - Market size and forecast 2025-2030 ($ million)
Exhibit 206: Data Table on Israel - Market size and forecast 2025-2030 ($ million)
Exhibit 207: Chart on Israel - Year-over-year growth 2025-2030 (%)
Exhibit 208: Data Table on Israel - Year-over-year growth 2025-2030 (%)
Exhibit 209: Chart on Colombia - Market size and forecast 2025-2030 ($ million)
Exhibit 210: Data Table on Colombia - Market size and forecast 2025-2030 ($ million)
Exhibit 211: Chart on Colombia - Year-over-year growth 2025-2030 (%)
Exhibit 212: Data Table on Colombia - Year-over-year growth 2025-2030 (%)
Exhibit 213: Market opportunity by geography ($ million)
Exhibit 214: Data Tables on Market opportunity by geography ($ million)
Exhibit 215: Impact of drivers and challenges in 2025 and 2030
Exhibit 216: Overview on criticality of inputs and factors of differentiation
Exhibit 217: Overview on factors of disruption
Exhibit 218: Impact of key risks on business
Exhibit 219: Companies covered
Exhibit 220: Company ranking index
Exhibit 221: Matrix on companies position and classification
Exhibit 222: AbbVie Inc. - Overview
Exhibit 223: AbbVie Inc. - Business segments
Exhibit 224: AbbVie Inc. - Key news
Exhibit 225: AbbVie Inc. - Key offerings
Exhibit 226: AbbVie Inc. - Segment focus
Exhibit 227: SWOT
Exhibit 228: Amgen Inc. - Overview
Exhibit 229: Amgen Inc. - Product / Service
Exhibit 230: Amgen Inc. - Key news
Exhibit 231: Amgen Inc. - Key offerings
Exhibit 232: SWOT
Exhibit 233: AstraZeneca Plc - Overview
Exhibit 234: AstraZeneca Plc - Business segments
Exhibit 235: AstraZeneca Plc - Key news
Exhibit 236: AstraZeneca Plc - Key offerings
Exhibit 237: AstraZeneca Plc - Segment focus
Exhibit 238: SWOT
Exhibit 239: Bayer AG - Overview
Exhibit 240: Bayer AG - Business segments
Exhibit 241: Bayer AG - Key news
Exhibit 242: Bayer AG - Key offerings
Exhibit 243: Bayer AG - Segment focus
Exhibit 244: SWOT
Exhibit 245: BioNTech SE - Overview
Exhibit 246: BioNTech SE - Product / Service
Exhibit 247: BioNTech SE - Key offerings
Exhibit 248: SWOT
Exhibit 249: Bristol Myers Squibb Co. - Overview
Exhibit 250: Bristol Myers Squibb Co. - Product / Service
Exhibit 251: Bristol Myers Squibb Co. - Key news
Exhibit 252: Bristol Myers Squibb Co. - Key offerings
Exhibit 253: SWOT
Exhibit 254: Eli Lilly and Co. - Overview
Exhibit 255: Eli Lilly and Co. - Product / Service
Exhibit 256: Eli Lilly and Co. - Key news
Exhibit 257: Eli Lilly and Co. - Key offerings
Exhibit 258: SWOT
Exhibit 259: F. Hoffmann La Roche Ltd. - Overview
Exhibit 260: F. Hoffmann La Roche Ltd. - Business segments
Exhibit 261: F. Hoffmann La Roche Ltd. - Key news
Exhibit 262: F. Hoffmann La Roche Ltd. - Key offerings
Exhibit 263: F. Hoffmann La Roche Ltd. - Segment focus
Exhibit 264: SWOT
Exhibit 265: GlaxoSmithKline Plc - Overview
Exhibit 266: GlaxoSmithKline Plc - Business segments
Exhibit 267: GlaxoSmithKline Plc - Key news
Exhibit 268: GlaxoSmithKline Plc - Key offerings
Exhibit 269: GlaxoSmithKline Plc - Segment focus
Exhibit 270: SWOT
Exhibit 271: Ipsen Pharma - Overview
Exhibit 272: Ipsen Pharma - Business segments
Exhibit 273: Ipsen Pharma - Key offerings
Exhibit 274: Ipsen Pharma - Segment focus
Exhibit 275: SWOT
Exhibit 276: Merck and Co. Inc. - Overview
Exhibit 277: Merck and Co. Inc. - Business segments
Exhibit 278: Merck and Co. Inc. - Key news
Exhibit 279: Merck and Co. Inc. - Key offerings
Exhibit 280: Merck and Co. Inc. - Segment focus
Exhibit 281: SWOT
Exhibit 282: Novartis AG - Overview
Exhibit 283: Novartis AG - Business segments
Exhibit 284: Novartis AG - Key news
Exhibit 285: Novartis AG - Key offerings
Exhibit 286: Novartis AG - Segment focus
Exhibit 287: SWOT
Exhibit 288: Sanofi SA - Overview
Exhibit 289: Sanofi SA - Business segments
Exhibit 290: Sanofi SA - Key news
Exhibit 291: Sanofi SA - Key offerings
Exhibit 292: Sanofi SA - Segment focus
Exhibit 293: SWOT
Exhibit 294: Takeda Pharmaceutical Ltd. - Overview
Exhibit 295: Takeda Pharmaceutical Ltd. - Business segments
Exhibit 296: Takeda Pharmaceutical Ltd. - Key news
Exhibit 297: Takeda Pharmaceutical Ltd. - Key offerings
Exhibit 298: Takeda Pharmaceutical Ltd. - Segment focus
Exhibit 299: SWOT
Exhibit 300: Thermo Fisher Scientific Inc. - Overview
Exhibit 301: Thermo Fisher Scientific Inc. - Business segments
Exhibit 302: Thermo Fisher Scientific Inc. - Key news
Exhibit 303: Thermo Fisher Scientific Inc. - Key offerings
Exhibit 304: Thermo Fisher Scientific Inc. - Segment focus
Exhibit 305: SWOT
Exhibit 306: Inclusions checklist
Exhibit 307: Exclusions checklist
Exhibit 308: Currency conversion rates for US$
Exhibit 309: Research methodology
Exhibit 310: Information sources
Exhibit 311: Data validation
Exhibit 312: Validation techniques employed for market sizing
Exhibit 313: Data synthesis
Exhibit 314: 360 degree market analysis
Exhibit 315: List of abbreviations
Exhibit 2: Executive Summary - Data Table on Market Overview
Exhibit 3: Executive Summary - Chart on Global Market Characteristics
Exhibit 4: Executive Summary - Chart on Market by Geography
Exhibit 5: Executive Summary - Chart on Market Segmentation by Type
Exhibit 6: Executive Summary - Chart on Market Segmentation by Application
Exhibit 7: Executive Summary - Chart on Market Segmentation by End-user
Exhibit 8: Executive Summary - Chart on Incremental Growth
Exhibit 9: Executive Summary - Data Table on Incremental Growth
Exhibit 10: Executive Summary - Chart on Company Market Positioning
Exhibit 11: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibit 12: Chart on Overview on criticality of inputs and factors of differentiation
Exhibit 13: Chart on Overview on factors of disruption
Exhibit 14: Chart on Impact of drivers and challenges in 2025 and 2030
Exhibit 15: Chart on Parent Market
Exhibit 16: Data Table on - Parent Market
Exhibit 17: Chart on Market characteristics analysis
Exhibit 18: Chart on Value chain analysis
Exhibit 19: Data Table on Offerings of companies included in the market definition
Exhibit 20: Market segments
Exhibit 21: Chart on Global - Market size and forecast 2025-2030 ($ million)
Exhibit 22: Data Table on Global - Market size and forecast 2025-2030 ($ million)
Exhibit 23: Chart on Global Market: Year-over-year growth 2025-2030 (%)
Exhibit 24: Data Table on Global Market: Year-over-year growth 2025-2030 (%)
Exhibit 25: Historic Market Size - Data Table on Global Cancer Immunotherapy Market 2020 - 2024 ($ million)
Exhibit 26: Historic Market Size - Type Segment 2020 - 2024 ($ million)
Exhibit 27: Historic Market Size - Application Segment 2020 - 2024 ($ million)
Exhibit 28: Historic Market Size - End-user Segment 2020 - 2024 ($ million)
Exhibit 29: Historic Market Size - Geography Segment 2020 - 2024 ($ million)
Exhibit 30: Historic Market Size - Country Segment 2020 - 2024 ($ million)
Exhibit 31: Five forces analysis - Comparison between 2025 and 2030
Exhibit 32: Bargaining power of buyers - Impact of key factors 2025 and 2030
Exhibit 33: Bargaining power of suppliers - Impact of key factors in 2025 and 2030
Exhibit 34: Threat of new entrants - Impact of key factors in 2025 and 2030
Exhibit 35: Threat of substitutes - Impact of key factors in 2025 and 2030
Exhibit 36: Threat of rivalry - Impact of key factors in 2025 and 2030
Exhibit 37: Chart on Market condition - Five forces 2025 and 2030
Exhibit 38: Chart on Type - Market share 2025-2030 (%)
Exhibit 39: Data Table on Type - Market share 2025-2030 (%)
Exhibit 40: Chart on Comparison by Type
Exhibit 41: Data Table on Comparison by Type
Exhibit 42: Chart on Monoclonal antibodies - Market size and forecast 2025-2030 ($ million)
Exhibit 43: Data Table on Monoclonal antibodies - Market size and forecast 2025-2030 ($ million)
Exhibit 44: Chart on Monoclonal antibodies - Year-over-year growth 2025-2030 (%)
Exhibit 45: Data Table on Monoclonal antibodies - Year-over-year growth 2025-2030 (%)
Exhibit 46: Chart on Check point inhibitors - Market size and forecast 2025-2030 ($ million)
Exhibit 47: Data Table on Check point inhibitors - Market size and forecast 2025-2030 ($ million)
Exhibit 48: Chart on Check point inhibitors - Year-over-year growth 2025-2030 (%)
Exhibit 49: Data Table on Check point inhibitors - Year-over-year growth 2025-2030 (%)
Exhibit 50: Chart on Cancer vaccines - Market size and forecast 2025-2030 ($ million)
Exhibit 51: Data Table on Cancer vaccines - Market size and forecast 2025-2030 ($ million)
Exhibit 52: Chart on Cancer vaccines - Year-over-year growth 2025-2030 (%)
Exhibit 53: Data Table on Cancer vaccines - Year-over-year growth 2025-2030 (%)
Exhibit 54: Market opportunity by Type ($ million)
Exhibit 55: Data Table on Market opportunity by Type ($ million)
Exhibit 56: Chart on Application - Market share 2025-2030 (%)
Exhibit 57: Data Table on Application - Market share 2025-2030 (%)
Exhibit 58: Chart on Comparison by Application
Exhibit 59: Data Table on Comparison by Application
Exhibit 60: Chart on Lung cancer - Market size and forecast 2025-2030 ($ million)
Exhibit 61: Data Table on Lung cancer - Market size and forecast 2025-2030 ($ million)
Exhibit 62: Chart on Lung cancer - Year-over-year growth 2025-2030 (%)
Exhibit 63: Data Table on Lung cancer - Year-over-year growth 2025-2030 (%)
Exhibit 64: Chart on Breast cancer - Market size and forecast 2025-2030 ($ million)
Exhibit 65: Data Table on Breast cancer - Market size and forecast 2025-2030 ($ million)
Exhibit 66: Chart on Breast cancer - Year-over-year growth 2025-2030 (%)
Exhibit 67: Data Table on Breast cancer - Year-over-year growth 2025-2030 (%)
Exhibit 68: Chart on Colorectal cancer - Market size and forecast 2025-2030 ($ million)
Exhibit 69: Data Table on Colorectal cancer - Market size and forecast 2025-2030 ($ million)
Exhibit 70: Chart on Colorectal cancer - Year-over-year growth 2025-2030 (%)
Exhibit 71: Data Table on Colorectal cancer - Year-over-year growth 2025-2030 (%)
Exhibit 72: Chart on Others - Market size and forecast 2025-2030 ($ million)
Exhibit 73: Data Table on Others - Market size and forecast 2025-2030 ($ million)
Exhibit 74: Chart on Others - Year-over-year growth 2025-2030 (%)
Exhibit 75: Data Table on Others - Year-over-year growth 2025-2030 (%)
Exhibit 76: Market opportunity by Application ($ million)
Exhibit 77: Data Table on Market opportunity by Application ($ million)
Exhibit 78: Chart on End-user - Market share 2025-2030 (%)
Exhibit 79: Data Table on End-user - Market share 2025-2030 (%)
Exhibit 80: Chart on Comparison by End-user
Exhibit 81: Data Table on Comparison by End-user
Exhibit 82: Chart on Hospitals and clinics - Market size and forecast 2025-2030 ($ million)
Exhibit 83: Data Table on Hospitals and clinics - Market size and forecast 2025-2030 ($ million)
Exhibit 84: Chart on Hospitals and clinics - Year-over-year growth 2025-2030 (%)
Exhibit 85: Data Table on Hospitals and clinics - Year-over-year growth 2025-2030 (%)
Exhibit 86: Chart on Cancer research centers - Market size and forecast 2025-2030 ($ million)
Exhibit 87: Data Table on Cancer research centers - Market size and forecast 2025-2030 ($ million)
Exhibit 88: Chart on Cancer research centers - Year-over-year growth 2025-2030 (%)
Exhibit 89: Data Table on Cancer research centers - Year-over-year growth 2025-2030 (%)
Exhibit 90: Market opportunity by End-user ($ million)
Exhibit 91: Data Table on Market opportunity by End-user ($ million)
Exhibit 92: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibit 93: Chart on Market share by geography 2025-2030 (%)
Exhibit 94: Data Table on Market share by geography 2025-2030 (%)
Exhibit 95: Chart on Geographic comparison
Exhibit 96: Data Table on Geographic comparison
Exhibit 97: Chart on North America - Market size and forecast 2025-2030 ($ million)
Exhibit 98: Data Table on North America - Market size and forecast 2025-2030 ($ million)
Exhibit 99: Chart on North America - Year-over-year growth 2025-2030 (%)
Exhibit 100: Data Table on North America - Year-over-year growth 2025-2030 (%)
Exhibit 101: Chart on Regional Comparison - North America
Exhibit 102: Data Table on Regional Comparison - North America
Exhibit 103: Chart on US - Market size and forecast 2025-2030 ($ million)
Exhibit 104: Data Table on US - Market size and forecast 2025-2030 ($ million)
Exhibit 105: Chart on US - Year-over-year growth 2025-2030 (%)
Exhibit 106: Data Table on US - Year-over-year growth 2025-2030 (%)
Exhibit 107: Chart on Canada - Market size and forecast 2025-2030 ($ million)
Exhibit 108: Data Table on Canada - Market size and forecast 2025-2030 ($ million)
Exhibit 109: Chart on Canada - Year-over-year growth 2025-2030 (%)
Exhibit 110: Data Table on Canada - Year-over-year growth 2025-2030 (%)
Exhibit 111: Chart on Mexico - Market size and forecast 2025-2030 ($ million)
Exhibit 112: Data Table on Mexico - Market size and forecast 2025-2030 ($ million)
Exhibit 113: Chart on Mexico - Year-over-year growth 2025-2030 (%)
Exhibit 114: Data Table on Mexico - Year-over-year growth 2025-2030 (%)
Exhibit 115: Chart on Europe - Market size and forecast 2025-2030 ($ million)
Exhibit 116: Data Table on Europe - Market size and forecast 2025-2030 ($ million)
Exhibit 117: Chart on Europe - Year-over-year growth 2025-2030 (%)
Exhibit 118: Data Table on Europe - Year-over-year growth 2025-2030 (%)
Exhibit 119: Chart on Regional Comparison - Europe
Exhibit 120: Data Table on Regional Comparison - Europe
Exhibit 121: Chart on Germany - Market size and forecast 2025-2030 ($ million)
Exhibit 122: Data Table on Germany - Market size and forecast 2025-2030 ($ million)
Exhibit 123: Chart on Germany - Year-over-year growth 2025-2030 (%)
Exhibit 124: Data Table on Germany - Year-over-year growth 2025-2030 (%)
Exhibit 125: Chart on UK - Market size and forecast 2025-2030 ($ million)
Exhibit 126: Data Table on UK - Market size and forecast 2025-2030 ($ million)
Exhibit 127: Chart on UK - Year-over-year growth 2025-2030 (%)
Exhibit 128: Data Table on UK - Year-over-year growth 2025-2030 (%)
Exhibit 129: Chart on France - Market size and forecast 2025-2030 ($ million)
Exhibit 130: Data Table on France - Market size and forecast 2025-2030 ($ million)
Exhibit 131: Chart on France - Year-over-year growth 2025-2030 (%)
Exhibit 132: Data Table on France - Year-over-year growth 2025-2030 (%)
Exhibit 133: Chart on Italy - Market size and forecast 2025-2030 ($ million)
Exhibit 134: Data Table on Italy - Market size and forecast 2025-2030 ($ million)
Exhibit 135: Chart on Italy - Year-over-year growth 2025-2030 (%)
Exhibit 136: Data Table on Italy - Year-over-year growth 2025-2030 (%)
Exhibit 137: Chart on Spain - Market size and forecast 2025-2030 ($ million)
Exhibit 138: Data Table on Spain - Market size and forecast 2025-2030 ($ million)
Exhibit 139: Chart on Spain - Year-over-year growth 2025-2030 (%)
Exhibit 140: Data Table on Spain - Year-over-year growth 2025-2030 (%)
Exhibit 141: Chart on The Netherlands - Market size and forecast 2025-2030 ($ million)
Exhibit 142: Data Table on The Netherlands - Market size and forecast 2025-2030 ($ million)
Exhibit 143: Chart on The Netherlands - Year-over-year growth 2025-2030 (%)
Exhibit 144: Data Table on The Netherlands - Year-over-year growth 2025-2030 (%)
Exhibit 145: Chart on Asia - Market size and forecast 2025-2030 ($ million)
Exhibit 146: Data Table on Asia - Market size and forecast 2025-2030 ($ million)
Exhibit 147: Chart on Asia - Year-over-year growth 2025-2030 (%)
Exhibit 148: Data Table on Asia - Year-over-year growth 2025-2030 (%)
Exhibit 149: Chart on Regional Comparison - Asia
Exhibit 150: Data Table on Regional Comparison - Asia
Exhibit 151: Chart on Japan - Market size and forecast 2025-2030 ($ million)
Exhibit 152: Data Table on Japan - Market size and forecast 2025-2030 ($ million)
Exhibit 153: Chart on Japan - Year-over-year growth 2025-2030 (%)
Exhibit 154: Data Table on Japan - Year-over-year growth 2025-2030 (%)
Exhibit 155: Chart on China - Market size and forecast 2025-2030 ($ million)
Exhibit 156: Data Table on China - Market size and forecast 2025-2030 ($ million)
Exhibit 157: Chart on China - Year-over-year growth 2025-2030 (%)
Exhibit 158: Data Table on China - Year-over-year growth 2025-2030 (%)
Exhibit 159: Chart on India - Market size and forecast 2025-2030 ($ million)
Exhibit 160: Data Table on India - Market size and forecast 2025-2030 ($ million)
Exhibit 161: Chart on India - Year-over-year growth 2025-2030 (%)
Exhibit 162: Data Table on India - Year-over-year growth 2025-2030 (%)
Exhibit 163: Chart on South Korea - Market size and forecast 2025-2030 ($ million)
Exhibit 164: Data Table on South Korea - Market size and forecast 2025-2030 ($ million)
Exhibit 165: Chart on South Korea - Year-over-year growth 2025-2030 (%)
Exhibit 166: Data Table on South Korea - Year-over-year growth 2025-2030 (%)
Exhibit 167: Chart on Taiwan - Market size and forecast 2025-2030 ($ million)
Exhibit 168: Data Table on Taiwan - Market size and forecast 2025-2030 ($ million)
Exhibit 169: Chart on Taiwan - Year-over-year growth 2025-2030 (%)
Exhibit 170: Data Table on Taiwan - Year-over-year growth 2025-2030 (%)
Exhibit 171: Chart on Singapore - Market size and forecast 2025-2030 ($ million)
Exhibit 172: Data Table on Singapore - Market size and forecast 2025-2030 ($ million)
Exhibit 173: Chart on Singapore - Year-over-year growth 2025-2030 (%)
Exhibit 174: Data Table on Singapore - Year-over-year growth 2025-2030 (%)
Exhibit 175: Chart on Rest of World (ROW) - Market size and forecast 2025-2030 ($ million)
Exhibit 176: Data Table on Rest of World (ROW) - Market size and forecast 2025-2030 ($ million)
Exhibit 177: Chart on Rest of World (ROW) - Year-over-year growth 2025-2030 (%)
Exhibit 178: Data Table on Rest of World (ROW) - Year-over-year growth 2025-2030 (%)
Exhibit 179: Chart on Regional Comparison - Rest of World (ROW)
Exhibit 180: Data Table on Regional Comparison - Rest of World (ROW)
Exhibit 181: Chart on Brazil - Market size and forecast 2025-2030 ($ million)
Exhibit 182: Data Table on Brazil - Market size and forecast 2025-2030 ($ million)
Exhibit 183: Chart on Brazil - Year-over-year growth 2025-2030 (%)
Exhibit 184: Data Table on Brazil - Year-over-year growth 2025-2030 (%)
Exhibit 185: Chart on Saudi Arabia - Market size and forecast 2025-2030 ($ million)
Exhibit 186: Data Table on Saudi Arabia - Market size and forecast 2025-2030 ($ million)
Exhibit 187: Chart on Saudi Arabia - Year-over-year growth 2025-2030 (%)
Exhibit 188: Data Table on Saudi Arabia - Year-over-year growth 2025-2030 (%)
Exhibit 189: Chart on South Africa - Market size and forecast 2025-2030 ($ million)
Exhibit 190: Data Table on South Africa - Market size and forecast 2025-2030 ($ million)
Exhibit 191: Chart on South Africa - Year-over-year growth 2025-2030 (%)
Exhibit 192: Data Table on South Africa - Year-over-year growth 2025-2030 (%)
Exhibit 193: Chart on Turkey - Market size and forecast 2025-2030 ($ million)
Exhibit 194: Data Table on Turkey - Market size and forecast 2025-2030 ($ million)
Exhibit 195: Chart on Turkey - Year-over-year growth 2025-2030 (%)
Exhibit 196: Data Table on Turkey - Year-over-year growth 2025-2030 (%)
Exhibit 197: Chart on UAE - Market size and forecast 2025-2030 ($ million)
Exhibit 198: Data Table on UAE - Market size and forecast 2025-2030 ($ million)
Exhibit 199: Chart on UAE - Year-over-year growth 2025-2030 (%)
Exhibit 200: Data Table on UAE - Year-over-year growth 2025-2030 (%)
Exhibit 201: Chart on Argentina - Market size and forecast 2025-2030 ($ million)
Exhibit 202: Data Table on Argentina - Market size and forecast 2025-2030 ($ million)
Exhibit 203: Chart on Argentina - Year-over-year growth 2025-2030 (%)
Exhibit 204: Data Table on Argentina - Year-over-year growth 2025-2030 (%)
Exhibit 205: Chart on Israel - Market size and forecast 2025-2030 ($ million)
Exhibit 206: Data Table on Israel - Market size and forecast 2025-2030 ($ million)
Exhibit 207: Chart on Israel - Year-over-year growth 2025-2030 (%)
Exhibit 208: Data Table on Israel - Year-over-year growth 2025-2030 (%)
Exhibit 209: Chart on Colombia - Market size and forecast 2025-2030 ($ million)
Exhibit 210: Data Table on Colombia - Market size and forecast 2025-2030 ($ million)
Exhibit 211: Chart on Colombia - Year-over-year growth 2025-2030 (%)
Exhibit 212: Data Table on Colombia - Year-over-year growth 2025-2030 (%)
Exhibit 213: Market opportunity by geography ($ million)
Exhibit 214: Data Tables on Market opportunity by geography ($ million)
Exhibit 215: Impact of drivers and challenges in 2025 and 2030
Exhibit 216: Overview on criticality of inputs and factors of differentiation
Exhibit 217: Overview on factors of disruption
Exhibit 218: Impact of key risks on business
Exhibit 219: Companies covered
Exhibit 220: Company ranking index
Exhibit 221: Matrix on companies position and classification
Exhibit 222: AbbVie Inc. - Overview
Exhibit 223: AbbVie Inc. - Business segments
Exhibit 224: AbbVie Inc. - Key news
Exhibit 225: AbbVie Inc. - Key offerings
Exhibit 226: AbbVie Inc. - Segment focus
Exhibit 227: SWOT
Exhibit 228: Amgen Inc. - Overview
Exhibit 229: Amgen Inc. - Product / Service
Exhibit 230: Amgen Inc. - Key news
Exhibit 231: Amgen Inc. - Key offerings
Exhibit 232: SWOT
Exhibit 233: AstraZeneca Plc - Overview
Exhibit 234: AstraZeneca Plc - Business segments
Exhibit 235: AstraZeneca Plc - Key news
Exhibit 236: AstraZeneca Plc - Key offerings
Exhibit 237: AstraZeneca Plc - Segment focus
Exhibit 238: SWOT
Exhibit 239: Bayer AG - Overview
Exhibit 240: Bayer AG - Business segments
Exhibit 241: Bayer AG - Key news
Exhibit 242: Bayer AG - Key offerings
Exhibit 243: Bayer AG - Segment focus
Exhibit 244: SWOT
Exhibit 245: BioNTech SE - Overview
Exhibit 246: BioNTech SE - Product / Service
Exhibit 247: BioNTech SE - Key offerings
Exhibit 248: SWOT
Exhibit 249: Bristol Myers Squibb Co. - Overview
Exhibit 250: Bristol Myers Squibb Co. - Product / Service
Exhibit 251: Bristol Myers Squibb Co. - Key news
Exhibit 252: Bristol Myers Squibb Co. - Key offerings
Exhibit 253: SWOT
Exhibit 254: Eli Lilly and Co. - Overview
Exhibit 255: Eli Lilly and Co. - Product / Service
Exhibit 256: Eli Lilly and Co. - Key news
Exhibit 257: Eli Lilly and Co. - Key offerings
Exhibit 258: SWOT
Exhibit 259: F. Hoffmann La Roche Ltd. - Overview
Exhibit 260: F. Hoffmann La Roche Ltd. - Business segments
Exhibit 261: F. Hoffmann La Roche Ltd. - Key news
Exhibit 262: F. Hoffmann La Roche Ltd. - Key offerings
Exhibit 263: F. Hoffmann La Roche Ltd. - Segment focus
Exhibit 264: SWOT
Exhibit 265: GlaxoSmithKline Plc - Overview
Exhibit 266: GlaxoSmithKline Plc - Business segments
Exhibit 267: GlaxoSmithKline Plc - Key news
Exhibit 268: GlaxoSmithKline Plc - Key offerings
Exhibit 269: GlaxoSmithKline Plc - Segment focus
Exhibit 270: SWOT
Exhibit 271: Ipsen Pharma - Overview
Exhibit 272: Ipsen Pharma - Business segments
Exhibit 273: Ipsen Pharma - Key offerings
Exhibit 274: Ipsen Pharma - Segment focus
Exhibit 275: SWOT
Exhibit 276: Merck and Co. Inc. - Overview
Exhibit 277: Merck and Co. Inc. - Business segments
Exhibit 278: Merck and Co. Inc. - Key news
Exhibit 279: Merck and Co. Inc. - Key offerings
Exhibit 280: Merck and Co. Inc. - Segment focus
Exhibit 281: SWOT
Exhibit 282: Novartis AG - Overview
Exhibit 283: Novartis AG - Business segments
Exhibit 284: Novartis AG - Key news
Exhibit 285: Novartis AG - Key offerings
Exhibit 286: Novartis AG - Segment focus
Exhibit 287: SWOT
Exhibit 288: Sanofi SA - Overview
Exhibit 289: Sanofi SA - Business segments
Exhibit 290: Sanofi SA - Key news
Exhibit 291: Sanofi SA - Key offerings
Exhibit 292: Sanofi SA - Segment focus
Exhibit 293: SWOT
Exhibit 294: Takeda Pharmaceutical Ltd. - Overview
Exhibit 295: Takeda Pharmaceutical Ltd. - Business segments
Exhibit 296: Takeda Pharmaceutical Ltd. - Key news
Exhibit 297: Takeda Pharmaceutical Ltd. - Key offerings
Exhibit 298: Takeda Pharmaceutical Ltd. - Segment focus
Exhibit 299: SWOT
Exhibit 300: Thermo Fisher Scientific Inc. - Overview
Exhibit 301: Thermo Fisher Scientific Inc. - Business segments
Exhibit 302: Thermo Fisher Scientific Inc. - Key news
Exhibit 303: Thermo Fisher Scientific Inc. - Key offerings
Exhibit 304: Thermo Fisher Scientific Inc. - Segment focus
Exhibit 305: SWOT
Exhibit 306: Inclusions checklist
Exhibit 307: Exclusions checklist
Exhibit 308: Currency conversion rates for US$
Exhibit 309: Research methodology
Exhibit 310: Information sources
Exhibit 311: Data validation
Exhibit 312: Validation techniques employed for market sizing
Exhibit 313: Data synthesis
Exhibit 314: 360 degree market analysis
Exhibit 315: List of abbreviations
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- AbbVie Inc.
- Amgen Inc.
- AstraZeneca Plc
- Bayer AG
- BioNTech SE
- Bristol Myers Squibb Co.
- Eisai Co. Ltd.
- Eli Lilly and Co.
- F. Hoffmann La Roche Ltd.
- GlaxoSmithKline Plc
- Incyte Corp.
- Ipsen Pharma
- Jiangsu Hengrui Pharmaceuticals
- Kyowa Kirin Co. Ltd.
- Merck and Co. Inc.
- Novartis AG
- Ono Pharmaceutical Co. Ltd.
- Regeneron Pharmaceuticals Inc.
- Sanofi SA
- Takeda Pharmaceutical Ltd.
- Thermo Fisher Scientific Inc.
